NKX2-5 genetic mutation in a young woman with an atrial septal defect presenting with complete heart block: ICD or bradycardia pacemaker?
Ahmed Y El-MedanyShahid AzizEdward DuncanPublished in: BMJ case reports (2023)
A woman in her 40s was admitted following syncope. The 12-lead ECG showed atrial fibrillation with slow ventricular response and suspected complete atrioventricular (AV) block. Cardiac monitoring demonstrated non-sustained monomorphic ventricular tachycardia (VT). Her medical history included surgical repair of an atrial septal defect (ASD) aged 4 years. The patient's mother died suddenly in her early 50s and also had an ASD. Given the patient's syncope, background of familial sudden cardiac death (SCD), suspicion of complete AV block and non-sustained VT, she received an implantable cardiac defibrillator (ICD). She underwent genetic testing, revealing a heterozygous NKX2-5 genetic mutation. The signature phenotype in NKX2-5 mutations is ASD with AV conduction disturbance and an increased risk of SCD secondary to ventricular arrhythmias or severe bradycardia. SCD has been described in NKX2-5 mutation carriers despite functioning permanent pacemakers (PPMs). Therefore, we propose implantation of a preventive ICD, as opposed to a PPM.
Keyphrases
- catheter ablation
- atrial fibrillation
- case report
- autism spectrum disorder
- left atrial
- left ventricular
- pulmonary embolism
- heart failure
- early onset
- left atrial appendage
- attention deficit hyperactivity disorder
- oral anticoagulants
- intellectual disability
- genome wide
- direct oral anticoagulants
- cardiac resynchronization therapy
- healthcare
- percutaneous coronary intervention
- heart rate
- copy number
- congenital heart disease
- acute coronary syndrome
- mitral valve
- dna methylation